Case Investigations

Juno Therapeutics, Inc.

July 18, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Juno Therapeutics, Inc. ("Juno” or the "Company") (Nasdaq: JUNO) for potential violations of the federal securities laws.  Investors who purchased shares of Juno’s common stock between June 4, 2016 and July 7, 2016 (the “Class Period”), may be affected.

Lipocine Inc.

July 12, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Lipocine Inc. ("Lipocine” or the "Company") (Nasdaq: LPCN) for potential violations of the federal securities laws.  Investors who purchased shares of Lipocine common stock between February 27, 2015 and June 28, 2016 (the “Class Period”), may be affected.

Signet Jewelers Ltd.

June 9, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Signet Jewelers Ltd. (“Signet Jewelers” or the “Company”) (NYSE: SIG), the world’s largest retailer of diamond jewelry.  Investors who purchased Signet Jewelers common stock between February 19, 2014 and June 2, 2016 may be affected.

Immunomedics, Inc.

June 3, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Immunomedics, Inc. (“Immunomedics” or the “Company”) (Nasdaq: (IMMU).  Investors who purchased Immunomedics securities between May 4, 2016 and June 2, 2016 may be affected.

CPI Card Group Inc.

May 12, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating CPI Card Group Inc. ("CPI Card Group” or the "Company") (Nasdaq: PMTS) for potential violations of the federal securities laws.  Investors who purchased CPI Card Group common stock since the Company’s October 8, 2015 initial public offering (“IPO”) may be affected.

Inventure Foods, Inc.

May 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Inventure Foods Inc. ("Inventure” or the "Company") (Nasdaq: SNAK) for potential violations of the federal securities laws.  Investors who purchased shares of Inventure common stock may be affected.

Credit Acceptance Corporation

May 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Credit Acceptance Corporation ("Credit Acceptance” or the "Company") (NASDAQ: CACC), a subprime auto lender, for potential violations of the federal securities laws.  Investors who purchased shares of Credit Acceptance common stock may be affected.

Halyard Health, Inc.

May 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Halyard Health, Inc. ("Halyard Health” or the "Company") (NYSE: HYH) for potential violations of the federal securities laws.  Investors who purchased shares of Halyard Health common stock or received shares pursuant to the October 2014 spin-off from Kimberly-Clark Corporation may be affected.

Natus Medical Incorporated

April 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Natus Medical Incorporated (“Natus” or the "Company") (Nasdaq: BABY).  Investors who purchased Natus securities between October 15, 2015 and April 1, 2016 may be affected.

Vericel Corporation

April 5, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Vericel Corporation (“Vericel” or the "Company") (Nasdaq: VCEL).  Investors who purchased Verical securities between March 10, 2016 and April 1, 2016 may be affected.

Restoration Hardware Holdings, Inc.

April 5, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Restoration Hardware Holdings, Inc. (“RH” or the "Company") (NYSE: RH).  Investors who purchased RH securities between October 12, 2015 and February 24, 2016 may be affected.

MFC Bancorp Ltd.

March 31, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating MFC Bancorp Ltd. (“MFC” or the “Company”) (NYSE: MFCB) on behalf of investors who purchased MFC securities.

LPL Financial Holdings Inc.

March 30, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating LPL Financial Holdings Inc. (“LPL” or the “Company”) on behalf of investors who purchased LPL securities between December 8, 2015 and February 11, 2016.

Fly Leasing Limited

March 30, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Fly Leasing Limited (“Fly Limited” or the “Company”) on behalf of investors who purchased Fly Limited securities between May 8, 2014 and March 7, 2016.

Amaya, Inc.

March 23, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Amaya, Inc. (“Amaya” or the "Company") (Nasdaq: AYA).  Investors who purchased Amaya securities between May 28, 2014 and March 22, 2016 may be affected.

GAIN Capital Holdings, Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating GAIN Capital Holdings, Inc. (“Gain” or the "Company") (NYSE: GCAP).  Investors who purchased Gain securities between February 27, 2014 and March 15, 2016 may be affected.

Santander Consumer USA Holdings Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Santander Consumer USA Holdings Inc. (“Santander” or the "Company") (NYSE: SC).  Investors who purchased Santander securities between February 2, 2015 and March 15, 2016 may be affected.

Alere Inc.

March 16, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Waltham, Massachusetts-based Alere Inc. (“Alere” or the "Company").

Aequitas Management LLC

March 10, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Oregon-based Aequitas Management LLC (“Aequitas” or the "Company").  On March 10, 2016, the U.S. Securities and Exchange Commission (“SEC”) charged Aequitas and three senior executives “with hiding the rapidly deteriorating financial condition of its enterprise while raising more than $350 million from investors."

Tangoe, Inc.

March 8, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Tangoe, Inc. ("Tangoe” or the "Company") (NASDAQ: TNGO) for potential violations of the federal securities laws.  Investors who purchased shares of Tangoe common stock between May 9, 2013 and March 7, 2016 may be affected.

Herbalife Ltd.

March 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Herbalife Ltd. ("Herbalife” or the "Company") (NYSE: HLF) for potential violations of the federal securities laws.  Investors who purchased shares of Herbalife common stock between August 5, 2015 and March 2, 2016 may be affected.

Third Avenue Management LLC

February 9, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Third Avenue Management LLC, Third Avenue Trust (“Third Avenue” or the “Trust”), and the Third Avenue Focused Credit Fund ( or the “Fund”) for potential violations of the securities laws.  Investors who purchased either Institutional or Investor shares of the Fund (NASDAQ: TCFIX or TFCVX) from March 1, 2013 through December 10, 2015 (the “Class Period”) may be affected.

Match Group, Inc.

February 3, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Match Group, Inc. (“Match” or the “Company”) (Nasdaq: MTCH) for potential violations of the federal securities laws.  Investors who purchased the Company’s common stock since the Company’s initial public offering of common stock on November 18, 2015 at $12 per share on may be affected.

Ooma Inc.

January 25, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Ooma Inc. ("Ooma” or the "Company") (NYSE: OOMA) for potential violations of the federal securities laws.  Investors who purchased Ooma common stock since the Company’s July 17, 2015 Initial Public Offering (the “IPO”)  may be affected.

Cnova NV

January 25, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Cnova NV ("Cnova” or the "Company") (Nasdaq: CNV) for potential violations of the federal securities laws.  Investors who purchased Cnova securities may be affected.

Sarepta Therapeutics

January 15, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Sarepta Therapeutics Inc. ("Sarepta” or the "Company") (Nasdaq: SRPT) for potential violations of the federal securities laws.  Investors who purchased shares of Sarepta common stock may be affected.

GoPro Inc.

January 14, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating GoPro Inc. (“GoPro” or the “Company”) (Nasdaq: GPRO) for potential violations of the federal securities laws.  Investors who purchased Company securities between July 21, 2015 and January 13, 2016 may be affected.

Fifth Street Asset Management, Inc.

January 12, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Fifth Street Asset Management, Inc. (“FSAM” or the “Company”) (NASDAQ: FSAM).  FSAM is a credit-focused asset manager and the investment advisor for Fifth Street Finance Corp. (“FSC”), Fifth Street Senior Floating Rate Corp. (“FSFR”), and various private Fifth Street funds. Investors who purchased shares of FSAM common stock in the Company’s October 29, 2014 initial public offering (“IPO”) or since the IPO may be affected.

Anavex Life Sciences Corporation

December 29, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Anavex Life Sciences Corporation (“Anavex” or the “Company”) (Nasdaq: AVXL) for potential violations of the federal securities laws.  Investors who purchased Company securities between October 25, 2015 and December 28, 2015 may be affected.

KaloBios Pharmaceuticals, Inc.

December 21, 2015 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating KaloBios Pharmaceuticals, Inc. ("KaloBios” or the “Company”) (NASDAQ: KBIO) for potential violations of the federal securities laws.  Investors who purchased KaloBios’ common stock may be affected.